As cannabis science continues to evolve, the industry is moving well beyond a singular focus on THC and CBD. Today, the most exciting breakthroughs are happening at the edges of the cannabinoid spectrum—where rare compounds with unique properties are finally becoming accessible at scale. One of the most compelling of these is CBGV (cannabigerovarin).
At GTR Seeds, we’re proud to be releasing new cannabis seed varieties bred to produce high levels of CBGV, marking a major milestone in cannabinoid-focused genetics.
What Is CBGV?
CBGV is the varin (three-carbon side chain) analog of CBG, often described as the “mother cannabinoid” from which many others are synthesized. Varin cannabinoids—such as THCV, CBDV, and CBGV—are known to interact differently with the endocannabinoid system than their more common pentyl counterparts. These subtle structural differences can lead to distinctly different biological activity and effects.
While CBG itself has gained attention for its potential anti-inflammatory, neuroprotective, and antibacterial properties, early research suggests CBGV may offer similar benefits with its own unique pharmacological profile. However, until recently, CBGV has existed almost exclusively in trace amounts, making meaningful research, product development, and commercialization extremely difficult.
Why High-CBGV Varieties Matter
The real breakthrough isn’t just that CBGV exists—it’s that it can now be expressed at commercially relevant levels. Developing stable cannabis varieties that reliably produce high amounts of CBGV requires advanced breeding strategies, deep genetic understanding, and years of selection work.
Historically, most cannabis plants favored THC or CBD production, with CBGV appearing only as a minor byproduct. Redirecting cannabinoid pathways toward CBGV expression represents a significant genetic achievement and opens the door to entirely new markets, formulations, and research opportunities.
For growers, high-CBGV varieties offer:
-
True market differentiation
-
Access to a rare and premium cannabinoid
-
Opportunities in emerging wellness, pharmaceutical, and specialty flower markets
For researchers and product developers, they provide something even more valuable: consistent, scalable access to CBGV-rich biomass.
Leading the Next Wave of Cannabinoid Innovation
For our crew, innovation has always meant pushing past what’s already common. Our new CBGV-producing seed varieties are the result of years of focused breeding, selection, and genetic refinement. These cultivars are designed not only to express high levels of CBGV, but to do so reliably, consistently, and in agronomically viable plants.
This release reflects a broader shift in cannabis toward intentional, cannabinoid-specific genetics—where plants are bred with purpose, precision, and end use in mind. CBGV is not a novelty; it’s a signal of where the industry is headed.
The Future Is Rare Cannabinoids
As consumer awareness grows and research expands, demand for rare cannabinoids will only increase. CBGV represents the next frontier—one with enormous scientific potential and real-world application. With the release of our high-CBGV varieties, we are proud to help make that future possible.
If you’re ready to be part of the next chapter in cannabis genetics, now is the time to explore what CBGV can offer.
